Status:

COMPLETED

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Tuberculosis

Eligibility:

All Genders

18-84 years

Phase:

PHASE4

Brief Summary

French guidelines currently recommend to initiate a 4-drug containing regimen associating isoniazid (INH or H), rifampicin (RIFor RMP or R), pyrazinamide (PZA or Z) and ethambutol (EMB or E) pending t...

Detailed Description

The impact of rapid detection of resistance with PCR has been poorly evaluated in low-endemic countries. In France, primary resistance to isoniazid and rifampicin were estimated at, respectively, 5.2%...

Eligibility Criteria

Inclusion

  • Adult patients
  • with active pulmonary tuberculosis (TB) and positive respiratory samples on microscopic examination for acid-fast bacilli (AFB+,) who are eligible for a standard TB treatment with a 4 drug combination
  • PCR (Genotype MTBDR Plus v2.0, Hain Lifescience) result available within the first 7 days of tuberculosis treatment.
  • who are seeking care in France (metropolitan or overseas) and accept a follow-up of 18 to 24 months after inclusion.
  • who have had a prior clinical examination

Exclusion

  • Refusal to participate in the study
  • Prior history of TB treatment
  • For women of child bearing age, pregnancy, willing to become pregnant or breastfeeding
  • Patient without healthcare insurance (French social security)
  • Patient participating in another clinical trial
  • Any condition that might compromise, in the investigator's opinion, patient's compliance with the protocol.
  • Results of cultures available at enrollment
  • No HIV testing available within the last 3 months prior to inclusion in the study.

Key Trial Info

Start Date :

July 23 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 18 2020

Estimated Enrollment :

204 Patients enrolled

Trial Details

Trial ID

NCT02231229

Start Date

July 23 2014

End Date

February 18 2020

Last Update

March 18 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Bichat Claude Bernard Hospital

Paris, France, 75018

2

Bichat hospital

Paris, France, 75018

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation | DecenTrialz